Macrophage Migration Inhibitory Factor (MIF) Promotes Increased Proportions of the Highly Permissive Th17-like Cell Profile during HIV Infection.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
09 10 2022
Historique:
received: 26 08 2022
revised: 04 10 2022
accepted: 06 10 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 29 10 2022
Statut: epublish

Résumé

In this study, we evaluate the role of the MIF/CD74 axis in the functionality of CD4

Identifiants

pubmed: 36298774
pii: v14102218
doi: 10.3390/v14102218
pmc: PMC9611675
pii:
doi:

Substances chimiques

Interleukin-17 0
Interleukin-6 0
Interleukin-8 0
Intramolecular Oxidoreductases EC 5.3.-
Macrophage Migration-Inhibitory Factors 0
MIF protein, human EC 5.3.2.1
Nuclear Receptor Subfamily 1, Group F, Member 3 0
Transcription Factors 0
invariant chain 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

Int J Mol Sci. 2018 Mar 03;19(3):
pubmed: 29510522
Immunity. 2006 Oct;25(4):595-606
pubmed: 17045821
Nat Med. 2007 May;13(5):587-96
pubmed: 17435771
Front Immunol. 2022 May 27;13:883728
pubmed: 35711433
Nat Med. 2009 Aug;15(8):893-900
pubmed: 19543283
J Virol. 2003 Oct;77(19):10548-56
pubmed: 12970439
Blood. 2008 Oct 1;112(7):2826-35
pubmed: 18664624
J Virol. 2016 Jan 15;90(2):670-81
pubmed: 26491172
Virology. 2010 Mar 30;399(1):31-38
pubmed: 20085845
Immunology. 2021 May;163(1):3-18
pubmed: 33064842
Cell Immunol. 2018 Feb;324:42-49
pubmed: 29397904
Front Immunol. 2018 Oct 23;9:2443
pubmed: 30405632
Annu Rev Pathol. 2020 Jan 24;15:123-147
pubmed: 31530089
Nat Immunol. 2021 Oct;22(10):1210-1217
pubmed: 34545250
Expert Opin Ther Targets. 2019 Sep;23(9):733-744
pubmed: 31414920
Arthritis Rheumatol. 2017 Feb;69(2):352-361
pubmed: 27564840
PLoS One. 2017 Nov 1;12(11):e0186823
pubmed: 29091911
AIDS. 2010 Feb 20;24(4):491-502
pubmed: 20071976
J Int AIDS Soc. 2011 Aug 10;14:40
pubmed: 21831310
Nat Med. 2021 Dec;27(12):2085-2098
pubmed: 34848888
Virus Res. 2012 Jan;163(1):380-4
pubmed: 21945129
Viruses. 2018 Jan 13;10(1):
pubmed: 29342870
Sci Rep. 2015 Jun 23;5:11511
pubmed: 26099972
J Biol Chem. 2005 May 20;280(20):19656-64
pubmed: 15749704
Semin Immunol. 2021 Jan;51:101438
pubmed: 33272901
Nat Immunol. 2007 Dec;8(12):1390-7
pubmed: 17994024
Trends Immunol. 2019 May;40(5):447-462
pubmed: 30962001
Curr Mol Med. 2018;18(10):679-688
pubmed: 30698113
Pathog Immun. 2017;2(2):179-192
pubmed: 28752134
AIDS. 2017 Oct 23;31(16):2211-2215
pubmed: 28857825
Front Immunol. 2018 Jun 27;9:1494
pubmed: 29997630
Pathog Immun. 2021 Oct 01;6(2):60-89
pubmed: 34988339
J Immunol Res. 2021 Sep 29;2021:7316456
pubmed: 34631899
J Virol. 2013 Jul;87(13):7445-62
pubmed: 23616666
PLoS One. 2014 Aug 05;9(8):e104235
pubmed: 25093660
Nat Rev Rheumatol. 2019 Jul;15(7):427-437
pubmed: 31197253
PLoS One. 2014 Mar 24;9(3):e92145
pubmed: 24662979
J Biol Chem. 2021 Jan-Jun;296:100434
pubmed: 33610555
Immunology. 2009 Jan;126(1):74-83
pubmed: 18624729
Cytokine. 2012 Nov;60(2):338-40
pubmed: 22898393
J Immunol. 2011 Jan 1;186(1):527-38
pubmed: 21106847
J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):1-6
pubmed: 30399040
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
pubmed: 18490657
J Exp Med. 2003 Jun 2;197(11):1467-76
pubmed: 12782713
Eur J Immunol. 2010 Jul;40(7):1830-5
pubmed: 20583029
Biochemistry. 1994 Nov 29;33(47):14144-55
pubmed: 7947826
Front Microbiol. 2021 Apr 07;12:646447
pubmed: 33897659
Biochem J. 2003 Aug 15;374(Pt 1):1-20
pubmed: 12773095
J Virol. 2015 Nov;89(22):11284-93
pubmed: 26339043
Sex Transm Infect. 2021 Feb;97(1):18-26
pubmed: 32732335
Immunity. 2013 Oct 17;39(4):633-45
pubmed: 24138880
Int J Mol Sci. 2022 Mar 11;23(6):
pubmed: 35328442
Lancet. 2014 Jul 19;384(9939):258-71
pubmed: 24907868
Bioorg Med Chem Lett. 2010 Oct 1;20(19):5811-4
pubmed: 20728358
Clin Microbiol Rev. 2019 Jul 31;32(4):
pubmed: 31366611
J Virol. 2014 Nov;88(21):12385-96
pubmed: 25122785
J Theor Biol. 2009 Nov 21;261(2):341-60
pubmed: 19660475
Cell. 2006 Sep 22;126(6):1121-33
pubmed: 16990136

Auteurs

César Trifone (C)

Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.
Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET-Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.

Lucía Baquero (L)

Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET-Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.
Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.

Alejandro Czernikier (A)

Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.
Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET-Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.

Paula Benencio (P)

Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.
Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET-Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.

Lin Leng (L)

Department of Medicine, Yale University School of Medicine, New Haven, CT 06510, USA.

Natalia Laufer (N)

Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET-Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.
Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.

María Florencia Quiroga (MF)

Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET-Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.
Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.

Richard Bucala (R)

Department of Medicine, Yale University School of Medicine, New Haven, CT 06510, USA.

Yanina Ghiglione (Y)

Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.
Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET-Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.

Gabriela Turk (G)

Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), CONICET-Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.
Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH